July 24, 2020
| The Hon. Peter Welch U.S. House of Representatives 2187 Rayburn House Office Building Washington, DC 20515 |
The Hon. Suzan DelBene U.S. House of Representatives 2330 Rayburn House Office Building Washington, DC 20515 |
| The Hon. Darin LaHood U.S. House of Representatives 1424 Longworth House Office Building Washington, DC 20515 |
Dear Reps. Welch, DelBene, LaHood:
On behalf of the undersigned organizations, we thank you for your leadership to ensure that value-based health care continues to serve Medicare patients by embracing higher value and lower cost. The Value in Health Care Act of 2020 makes a number of important reforms to strengthen Medicare’s value-based care models and Accountable Care Organizations (ACOs) to ensure that these models continue to produce high quality care for the Medicare program and its beneficiaries as well as to generate savings for taxpayers. With estimates showing almost forty percent1 of healthcare dollars are tied to value-based payment and goals to increase that percent moving forward, the value-based care movement is at a critical juncture.
Explore Related Content
Federal Policy Resource
Analysis: Final 2021 Medicare Physician Payment and Quality Reporting Changes
Federal Policy Resource
CMS Accelerated and Advance Payment Program
Federal Policy Resource
Key provisions affecting medical groups in the CARES Act
More Advocacy Letters
Advocacy Letter
MGMA to DEA: Issue proposed telehealth rule (April 2, 2024)
Advocacy Letter
MGMA letter to Congress on LDT proposed rule (March 20, 2024)
Advocacy Letter
March 14, 2024 - MGMA urges permanent telehealth reform
Advocacy Letter
December 4, 2023: MGMA comments on proposed LDT rule
Advocacy Letter
November 13, 2023: MGMA comments on Section 504
Advocacy Letter
November 7, 2023: MGMA feedback on Senate healthcare package
Advocacy Letter
November 1, 2023: MGMA requests pause on LDT rulemaking
Advocacy Letter
October 31, 2023: MGMA urges budget neutrality reforms
